Healthcare

Five Questions with Adam Feinstein, founder of healthcare-focused Vesey Street

"We’re investing in healthcare services companies in the Ebitda range of $5 million to $30 million that offer meaningful growth opportunities."

AtriCure to acquire VC-backed SentreHEART

AtriCure Inc has agreed to acquire Redwood City, California-based SentreHEART Inc, a developer of percutaneous left atrial appendage management solutions, for upwards of $300 million. The deal is expected to close in the next several days. SentreHEART's backers include Deerfield Management Company, U.S. Venture Partners, Prospect Ventures, Vivo Capital and Decheng Capital.

Renovacor snags $11 mln Series A

Renovacor Inc, a preclinical-stage biopharmaceutical company focused on developing gene therapy-based treatments for cardiovascular disease, has raised $11 million in Series A financing. Novartis Venture Fund, Broadview Ventures and BioAdvance led the round with participation from New Leaf Venture Partners and Innogest Capital.

Equistone Partners buys majority of Omnicare

Equistone Partners Europe said Aug. 14 that it agreed to buy a majority of Omnicare. Financial terms weren’t announced. Omnicare is a pharmaceutical wholesaler operating throughout Germany that distributes products to compounding pharmacies that serve oncological patients across Germany.

CityMD closes Summit Medical merger

CityMD, which is backed by Warburg Pincus, has completed its merger with Summit Medical Group. The deal was announced in June.

Baze nabs $6 mln Series A

Baze, a provider of a blood-based, at home nutritional testing kit, has raised $6 million in Series A funding. Nature's Way was the lead investor.

Summit Partners said to invest in Florida’s Pediatric Associates

The transaction was done outside of a formal process with no sell-side adviser engaged.

GPP amasses $306 mln for third fund

Great Point Partners has closed its third growth buyout fund at a hard cap of $306 million, beating its $250 million target. GPP III's limited partners include endowments, foundations, family offices, banks and pension funds. The fund will invest in healthcare companies. Morrison Cohen LLP acted as legal counsel for GPP III.

German molecular diagnostics firm GNA Biosolutions picks up $13.5 mln Series C

GNA Biosolutions GmbH, a German molecular diagnostics company, has secured $13.5 million in Series C financing. The investors included GreyBird Ventures, Occident, Wachtumsfonds Bayern, SHS Gesellschaft für Beteiligungsmanagement, Robert Bosch Venture Capital, UVC Partners, Mey Capital Matrix, KfW and btov Partners.

Landos Biopharma rakes in $60 mln Series B

Blacksburg, Virginia-based Landos Biopharma Inc, a clinical-stage biopharmaceutical company, has raised $60 million in Series B financing. RTW Investments and Perceptive Advisors led the round.